20+ years managing quality and compliance organizations
Deep knowledge of cgmp/gdp regulations
Experience with biologics and pharma manufacturing
This role defines the Quality strategy for the Global Business Unit Manufacturing Network to ensure cGMP compliance and product safety across biologics and pharma units
Job Summary
This role defines the Quality strategy for the Global Business Unit Manufacturing Network to ensure cGMP compliance and product safety across biologics and pharma units.
The Vice President will lead a multi-functional team of quality professionals, manage site quality heads, and collaborate with global manufacturing and supply chain functions.
Bristol Myers Squibb offers competitive benefits including health coverage, financial protection, flexible time off, and a supportive culture focused on transforming patients' lives.
Matching Summary
This role defines the Quality strategy for the Global Business Unit Manufacturing Network to ensure cGMP compliance and product safety across biologics and pharma units.
Salary
Base: $333,760 - $404,440; Bonus/Equity: Additional incentive cash and stock opportunities available; Benefits: Comprehensive medical, dental, vision, 401(k), paid time off, and wellbeing programs
Skills & Requirements
Must-have
20+ years managing quality and compliance organizations
Deep knowledge of cGMP/GDP regulations
Experience with biologics and pharma manufacturing
Proven track record in regulatory remediation
Expertise in Quality Management Systems (QMS)
Strong background in Health Authority inspections
Nice-to-have
Strategic thinking with high business acumen
Ability to influence in a matrix environment
Experience recruiting and developing global talent
Championing innovative digital solutions
Excellent communication and interpersonal skills
Key Requirements
B.S. degree in Science or Engineering (Advanced degree preferred)
20+ years of experience in quality and compliance management
Thorough understanding of pharmaceutical/biological manufacturing technical areas
Demonstrated success in compliance remediation activities